Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT and Psyllium Fiber in Ulcerative Colitis
NCT03998488Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 2020
- Primary completion
- Jun 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in ulcerative colitis (UC), sponsored by Weill Cornell Medicine. Started Jan 2020; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03998488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03998488.